News Articles

Stephen Dawson (left) with Emyria’s Michael Winlo and Mary-Ann Rennie, and Wesfarmers media-public affairs manager Rebecca Keenan at the awards. Photo: Matt Jelonek.

Technology, Innovation & Science 21 May 2026

Emyria moves on clinical drugs play

A Perth-based company could win big from a change in US health policy.

Emyria chief scientist Michael Winlo gave an impassioned speech as he accepted Emyria's Innovator of the Year - Wellbeing Category win in November. Photo: Matt Jelonek.

Health 16 Feb 2026

Emyria gains Medibank backing for Victoria

Treatments from an innovative Perth healthcare company offering novel MDMA and psilocybin-assisted therapy for PTSD will be covered by insurance in three states, after it expanded an agreement with Medibank.

Nedlands-based medtech company Proteomics has appointed a new managing director and chief executive. Photo: Proteomics.

Health 30 Jan 2026

How WA medical stocks fared last quarter

Several WA-based ASX-listed medical companies hit key milestones this quarter, signalling a strong year ahead for the sector.

Main pic: Richard T on Unsplash. Inset: Zelira CEO and Global Managing Director Dr. Oludare Odumosu.

Health 16 Jan 2026

Perth cannabis company in $33m deal

WA's medicinal cannabis industry has notched another win for the week, with Zelira Therapeutics attaining $33 million in non-dilutive funding for its cannabis-based autism treatment.

Technology, Innovation & Science 16 Dec 2025

WA-founded MDMA PTSD treatment to enter Victoria

A WA Innovator of the Year award winner has announced it will bring its novel MDMA and psilocybin-assisted therapy for post traumatic stress disorder to Victoria.

The 2025 Innovator of the Year award winners.

Technology, Innovation & Science 03 Nov 2025

Greenroom, ProGenis, Safestyle named Innovators of the Year

Bluetooth pill dispensers, autonomous ship navigation, stylish safety glasses, and MDMA and Psilocybin-assisted therapy have been recognised at this year's Innovator of the Year awards night.

Health 22 Sep 2025

Medibank bolsters Emyria deal

The private insurer is the first major brand to fund a psychotherapy-led treatment-resistant depression program in Australia.

Emyria will bring its Empax clinic to Avive’s 63-bed private hospital in Brisbane this year. Photo: Avive Health

Health 29 Jul 2025

Emyria lands Avive Health deal

Emyria wants to roll out its psychedelic-assisted mental health treatments nation-wide under recent agreements with Medibank and Avive Health.

Appointments 21 Nov 2023

Board Moves November 21, 2023

Our board moves wrap includes Luke Meter, YaXi Zhan, Greg Hutchinson, Henry Heng, Colin Moran, Richard Mei, Brett Crowley, and Aldo Miccio.

Appointments 13 Nov 2023

Board Moves November 13, 2023

Our board moves wrap includes Alistair Vickery, Stewart Washer, Karen Smith, Tracey Horton, Peter Gundy, Clint Moxham, Carla Healy, Damon Fieldgate, Paul Farrell, and Andrew Brown.

Appointments 21 Aug 2023

Board Moves August 21, 2023

Our board moves wrap includes Jeremy Robinson, Matt Freedman, Michelle Roth, Bruce McFadzean, Mohit Kaushal, Matt Callahan, Simon Linge, and Bruce Munro.

Technology, Innovation & Science 10 Aug 2023

State, VCs drive healthtech push

Health tech has taken a front seat in recent months thanks to the combined funding from government and private sectors.

Appointments 01 Mar 2023

Board Moves March 1, 2023

Our board moves wrap includes Chris Radin, Sheila Khama, Stirling Ross, Gerry Kaczmarek, Tony Kiernan, Derek Humphry, Dale Richards, Nerida Schmidt, Patricia Farr, Simon Robertson, Susan Park, Peter Webse, ChongTao Xu, Andrew Taplin, Carol Marinkovich, Rowan Harland, Arron Canicais, David Lim, Andrew Woskett, Benjamin Donovan, and Shaun Menezes.

Health 07 Nov 2022

Healthtech banks on rising numbers

The commercial side of life sciences may have reached a critical mass in WA.

Health 15 Aug 2022

Healthech focus for new Forrest VC fund

A $250 million venture capital initiative launched by the Forrest family seeks to leverage the millions of dollars of health-related R&D funding by governments and bridge the commercialisation 'valley of death' faced by many startups.

Technology, Innovation & Science 13 May 2022

Reset revives the magic of mycology

Graham Upson is sharing his knowledge with a company seeking to grow mushrooms for mental health.

Technology, Innovation & Science 20 Jan 2022

Emyria to begin cannabis trial

Andrew Forrest-backed Emyria is slated to start human clinical trials within weeks for a cannabinoid drug to treat psychological distress.

Appointments 29 Nov 2021

Board Moves November 29, 2021

Our board moves wrap includes Neville Bassett, Neil Marston, Michele Anderson, Karen Smith, Debra Singh, Toni Thornton, David Foster, Mark Johnson, Gerard McMahon, Neale Edwards, and Matt Briggs.

Technology, Innovation & Science 22 Nov 2021

Forrest pitches in for cannabis research

Shares in Perth-based medicinal cannabis aspirant Emyria were up as much as 21 per cent after the business revealed a $5 million backing from Andrew Forrest's investment business, Tattarang.

Technology, Innovation & Science 19 May 2021

INCITE 2021 Awards finalists announced

Fifty Perth-based companies and organisations - including education institutions, numerous local startups and not for profits and mining giants have been announced as finalists for the INCITE Award

Appointments 22 Feb 2021

Board Moves February 22, 2021

Our board moves wrap includes Stephen McIntosh, Manuel Ramos, Karen Smith, Tom Wilcox, and Oonagh Malone.

Deals 20 Jan 2021

Advisers enjoy strong flow of listings

A post-pandemic bounce back in initial public offerings could indicate confidence among WA investors.

Agribusiness 15 Dec 2020

Research a driver for cannabis

The strong growth of the medicinal cannabis industry will need to be supported by research for the sector to take the next step.

Technology, Innovation & Science 14 Sep 2020

More than Linear growth for drug trials in COVID-free WA

Perth's largest drug testing company plans to nearly double capacity as WA attracts attention from global pharmaceutical companies.

Deals 22 Jul 2020

IPOs smashed by pandemic

COVID-19 has taken a wrecking ball through the IPO market, cutting raisings by 80 per cent, although those that proceeded outperformed other equities.

Deals 11 Feb 2020

Perth cannabis companies raise $16m from IPOs

Emerald Clinics and Little Green Pharma have both completed their initial public offerings ahead of stock market listings this month, with Emerald getting ready for its ASX debut tomorrow.

Health 11 Feb 2020

Medical leaders selected to develop sector plan

The state government has appointed an industry reference group to develop a growth plan for WA's health and medical life sciences sector to be chaired by Peter Klinken.

Deals 07 Jan 2020

Medicinal cannabis IPOs seek $18m

Perth companies Emerald Clinics and Little Green Pharma are seeking to raise up to $18 million ahead of stock market listings as they pursue very different strategies in the medicinal cannabis market.

Health 24 Oct 2019

Emerald targets green medicine growth

With mainstream acceptance for cannabinoid medicines growing, Emerald Clinics has found value in building clinical evidence of its use.

News 03 Oct 2019

Winlo joins Emerald Clinics

Medicinal cannabis research company Emerald Clinics has boosted its management team with the appointment of Michael Winlo as chief executive, ahead of an expected IPO later this year.

News Articles for Emyria

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark

Bookmark